Jennerex Adds Industry Veteran Paul Cleveland to Board of Directors

30-Apr-2010 - USA

Jennerex, Inc. expanded its board of directors with the appointment of Paul B. Cleveland, executive vice president of corporate development and chief financial officer of Affymax, Inc.

Mr. Cleveland brings over 20 years of experience in strategic corporate transactions and investment banking to the Jennerex board. As executive vice president of corporate development and chief financial officer for Affymax, he manages all business development, strategic planning, financial and legal activities. Prior to Affymax, he served as managing director of the investment banks Integrated Finance, Ltd. and J.P. Morgan Chase and Co. (formerly Hambrecht & Quist), leading healthcare and technology mergers and acquisitions for the firms. Prior to his tenure in investment banking, he was a partner at Cooley Godward LLP. Mr. Cleveland serves as a member of the board of directors of Sangamo BioSciences, Inc. He holds a J.D. from Northwestern University School of Law and an A.B. from Washington University in St. Louis.

Other news from the department people

More news from our other portals

All FT-IR spectrometer manufacturers at a glance

Last viewed contents